Graig Suvannavejh's
Stock Forecasts

Graig Suvannavejh win rate

7.41%

2/27 win trades

Graig Suvannavejh is a Wall Street stock analyst with a 7.41% win rate, who was right in predicting 2 out of 27 price targets. Most frequently covered stocks by this analyst are APLS, HRMY, IDYA and IMCR. He has published 0 price targets in the last month and 2 last year.

Price targets by Graig Suvannavejh

Company name & ticker Publish date Price target Price when posted Source Historical targets
CRVS logo
Corvus Pharmaceuticals, Inc.
CRVS
 11 months ago $12 133.46% upside $7.56 StreetInsider Previous targets (0)
HRMY logo
Harmony Biosciences Holdings, Inc.
HRMY
 12 months ago $52 41.49% upside $33.6 TheFly
IDYA logo
IDEAYA Biosciences, Inc.
IDYA
 about 1 year ago $55 133.24% upside $31.37 StreetInsider
ADVM logo
Adverum Biotechnologies, Inc.
ADVM
 about 1 year ago $20 604.22% upside $7.5 StreetInsider Previous targets (0)
APLS logo
Apellis Pharmaceuticals, Inc.
APLS
 about 1 year ago $39 46.50% upside $36.73 StreetInsider
CRBP logo
Corbus Pharmaceuticals Holdings, Inc.
CRBP
 about 1 year ago $74 710.51% upside $51.58 StreetInsider Previous targets (0)
IMCR logo
Immunocore Holdings plc
IMCR
 about 1 year ago $72 122.63% upside $33.44 StreetInsider
AXSM logo
Axsome Therapeutics, Inc.
AXSM
 about 1 year ago $106 -5.35% downside $90.58 StreetInsider
TERN logo
Terns Pharmaceuticals, Inc.
TERN
 about 1 year ago $10 58.47% upside $7.79 StreetInsider Previous targets (0)
NMRA logo
Neumora Therapeutics, Inc. Common Stock
NMRA
 about 1 year ago $20 1112.04% upside $10.25 TheFly Previous targets (0)
ITCI logo
Intra-Cellular Therapies, Inc.
ITCI
 over 1 year ago $100 -24.16% downside $76.06 StreetInsider Previous targets (0)
INSM logo
Insmed Incorporated
INSM
 over 1 year ago $82 -35.64% downside $57.17 StreetInsider
ADAP logo
Adaptimmune Therapeutics plc
ADAP
 over 1 year ago $3 4809.98% upside $1.2 TheFly Previous targets (0)
IMTX logo
Immatics N.V.
IMTX
 over 1 year ago $16 180.70% upside $11.08 TheFly Previous targets (0)
AMLX logo
Amylyx Pharmaceuticals, Inc.
AMLX
 over 1 year ago $3 -61.73% downside $1.82 StreetInsider
EYPT logo
EyePoint Pharmaceuticals, Inc.
EYPT
 over 1 year ago $30 171.73% upside $11.2 StreetInsider Previous targets (0)
IMRX logo
Immuneering Corporation
IMRX
 over 1 year ago $8 136.68% upside $2.75 StreetInsider Previous targets (0)

Other analysts covering same stocks

Ashwani Verma
Bank of America Securities
100%
win rate
Covering:
Tiago Fauth
Credit Suisse
85.71%
win rate
Covering:
AMGNAPLSBMRNFMTXRXDXUTHR …
Laura Chico
Wedbush
57.14%
win rate
Covering:
APLSARDXBIIBLRMRNBIXPHVS …
Marc Goodman
Leerink Partners
50%
win rate
Covering:
Geoff Meacham
Bank of America Securities
37.5%
win rate
Covering:
ABBVAMGNAMLXBIIBBMRNBMY …
Yatin Suneja
Guggenheim
33.33%
win rate
Covering:
ACADANABARGXAXSMBIIBIMVT …
Alethia Young
Cantor Fitzgerald
33.33%
win rate
Covering:
ALNYAPLSASNDBIIBGBTICPT …
Michael Yee
Jefferies
30.77%
win rate
Covering:
AMGNBIIBDNLIFATEGILDICPT …
Vamil Divan
Guggenheim
30%
win rate
Covering:
ABBVALPNEXLSGSKINSMKROS …
Geulah Livshits
Chardan Capital
28.57%
win rate
Covering:
Derek Archila
Wells Fargo
26.92%
win rate
Covering:
ANNXAPLSARGXARVNBPMCCCCC …
Akash Tewari
Jefferies
26.92%
win rate
Covering:
ALKSAPLSARGXBNTXCYTKEXEL …
Corinne Jenkins
Goldman Sachs
25%
win rate
Covering:
ALECFULCGERNHALOHRMYIDYA …
Maury Raycroft
Jefferies
25%
win rate
Covering:
ALNYBCRXCALTCRBPCRSPCUE …
Andrew Tsai
Jefferies
25%
win rate
Covering:
ATHAGEVITCIRAPPRLMDSRPT …
Sumant Kulkarni
Canaccord Genuity
22.22%
win rate
Covering:
ANVSBIIBCARACLNNCRVOITCI …
Paul Matteis
Stifel Nicolaus
22.22%
win rate
Covering:
ACADALKSALNYBIIBBMRNCTNM …
Gregory Renza
RBC Capital
20%
win rate
Covering:
AGIOAMGNCATXCRMDFULCIDYA …
Andrea Tan
Goldman Sachs
20%
win rate
Covering:
ABCLARWRFATEINSMJAZZKOD …
Justin Kim
Oppenheimer
20%
win rate
Covering:
Bill Maughan
Canaccord Genuity
20%
win rate
Covering: